We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
-2.14%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$3.35B
AUM Growth
-$84.7M
Cap. Flow
+$67.8M
Cap. Flow %
2.02%
Top 10 Hldgs %
96.08%
Holding
32
New
19
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$81.6M
2
VRNA
Verona Pharma
VRNA
+$53.1M
3
HLVX
HilleVax
HLVX
+$29.4M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$25.8M
5
VERA icon
Vera Therapeutics
VERA
+$22.8M

Top Sells

Rank Stock Value
1
ONEM
1Life Healthcare
ONEM
+$227M
2
SPNT icon
SiriusPoint
SPNT
+$764K

Sector Composition

Rank Sector Weight
1 Technology 51.72%
2 Healthcare 40.68%
3 Consumer Staples 4.25%
4 Communication Services 1.81%
5 Real Estate 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.24B
$1.11B 33.11%
12,460,183
– –
GTM
2
ZoomInfo Technologies
GTM
$922M
$906M 27.02%
36,662,469
– –
MKSI icon
3
MKS Inc
MKSI
$22.4B
$752M 22.43%
8,482,732
– –
VTRU
4
DELISTED
Vitru Limited Common Shares
VTRU
$142M 4.24%
6,246,471
– –
GDS icon
5
GDS Holdings
GDS
$6.56B
$76M 2.27%
4,072,624
+295,200
+8% +$6.25M
PCVX icon
6
Vaxcyte
PCVX
$8.09B
$72.1M 2.15%
+1,923,158
New +$81.6M
GETY icon
7
Getty Images
GETY
$223M
$60.6M 1.81%
11,902,817
– –
VRNA
8
DELISTED
Verona Pharma
VRNA
$49.3M 1.47%
+2,457,500
New +$53.1M
HLVX
9
DELISTED
HilleVax
HLVX
$30.1M 0.9%
+1,838,486
New +$29.4M
VERA icon
10
Vera Therapeutics
VERA
$2.81B
$22.9M 0.68%
+2,960,231
New +$22.8M
PHAT icon
11
Phathom Pharmaceuticals
PHAT
$875M
$20.9M 0.62%
+2,935,106
New +$25.8M
JSPR icon
12
Jasper Therapeutics
JSPR
$21.7M
$15.8M 0.47%
+876,189
New +$16.2M
INVH icon
13
Invitation Homes
INVH
$18.1B
$14.9M 0.44%
+477,500
New +$15M
OKUR
14
OnKure Therapeutics
OKUR
$166M
$12.2M 0.37%
+207,396
New +$7.52M
ACET icon
15
Adicet Bio
ACET
$76.8M
$12.2M 0.36%
+132,212
New +$16.6M
LSI
16
DELISTED
Life Storage, Inc.
LSI
$11.3M 0.34%
86,000
– –
CUBE icon
17
CubeSmart
CUBE
$9.53B
$10.2M 0.3%
220,500
– –
SMHI icon
18
SEACOR Marine Holdings
SMHI
$212M
$10M 0.3%
1,314,043
+117,394
+10% +$1.12M
SPRB
19
Spruce Biosciences
SPRB
$122M
$6.4M 0.19%
+38,620
New +$7.17M
EM
20
DELISTED
Smart Share Global Ltd
EM
$5.34M 0.16%
4,810,209
– –
NCNA
21
NuCana
NCNA
$5.54M
$3.2M 0.1%
+667
New +$4.58M
PRTK
22
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.62M 0.08%
+1,041,131
New +$2.06M
SLNO
23
DELISTED
Soleno Therapeutics
SLNO
$2.54M 0.08%
+1,201,506
New +$2.7M
EFTR
24
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.69M 0.05%
+192,885
New +$2.34M
CBAY
25
DELISTED
Cymabay Therapeutics
CBAY
$1.14M 0.03%
+131,036
New +$1.05M
1
2

Similar funds

SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Carlyle Group's Q1 2023 Portfolio in Review

As of Q1 2023, Carlyle Group held 32 positions worth $3.35B, down 2.5% from $3.44B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Carlyle Group's Q1 2023 filing shows 19 new, 2 increased and 2 closed positions. Its largest new stake was Vaxcyte: 1,923,158 shares worth $72.1M. The largest sale was 1Life Healthcare, an estimated $227M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 55% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Carlyle Group's largest Q1 2023 buy was Vaxcyte: 1,923,158 shares worth $72.1M.
  • Carlyle Group added most to GDS Holdings in Q1 2023, an estimated $6.25M increase.
  • Carlyle Group fully exited 1Life Healthcare in Q1 2023, selling an estimated $227M.
  • Carlyle Group's ten largest holdings make up 96% of its $3.35B portfolio in Q1 2023.
  • Carlyle Group opened 19 new positions and closed 2 in Q1 2023.
  • Carlyle Group's portfolio value fell 2.5% quarter-over-quarter to $3.35B.

Based on Carlyle Group's 13F filing for Q1 2023, filed 5 May 2023.